Red man syndrome and infliximab.
Lobel
Efrat Z
EZ
Korelitz
Burton I
BI
Warman
Jonathan I
JI
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000209:etiology*; D004890:Erythema / Q000139:chemically induced; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced; D013577:Syndrome; D017211:Treatment Failure; D014581:Urticaria / Q000139:chemically induced
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab